Talphera (TLPH) Income from Discontinued Operations (2022 - 2025)
Talphera (TLPH) posted Income from Discontinued Operations of $73000.0 for Q1 2025, up 708.33% on a QoQ basis from -$12000.0 in Q4 2023.
Analysis
Talphera (TLPH) Income from Discontinued Operations (2022 - 2025) Analysis & Trends
Talphera has reported Income from Discontinued Operations for 3 years, with the latest figure at $73000.0 in Q1 2025.
- On a quarterly basis, Income from Discontinued Operations changed N/A year-over-year to $73000.0 in Q1 2025; TTM through Dec 2025 was $73000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $73000.0, changed N/A from the prior year.
- Income from Discontinued Operations was $73000.0 for Q1 2025 at Talphera, up from -$12000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was $8.2 million in Q1 2023, with the low at -$4.1 million in Q1 2022.
- Average Income from Discontinued Operations over 3 years is -$330555.6, with a median of -$12000.0 recorded in 2023.
- The largest YoY upside for Income from Discontinued Operations was 302.41% in 2023 against a maximum downside of 99.22% in 2023.
- Over 3 years, Income from Discontinued Operations stood at -$1.5 million in 2022, then surged by 99.22% to -$12000.0 in 2023, then surged by 708.33% to $73000.0 in 2025.
- The last three Income from Discontinued Operations figures came in at $73000.0 (Q1 2025), -$12000.0 (Q4 2023), and $61000.0 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.67 Bn | 192.69 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.06 Bn | 176.88 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.44 Bn | 123.59 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.87 Bn | 48.73 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.15 Bn | 29.85 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.88 Bn | 30.60 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.16 Bn | 29.16 Bn | 1.16 Mn | - |
| 10 | Talphera | 93.28 Mn | 93.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 8.22 Mn |
| Dec 31, 2022 | -1.55 Mn |
| Sep 30, 2022 | -2.11 Mn |
| Jun 30, 2022 | -3.65 Mn |
| Mar 31, 2022 | -4.06 Mn |